ATE398628T1 - Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro- - Google Patents

Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-

Info

Publication number
ATE398628T1
ATE398628T1 AT01949791T AT01949791T ATE398628T1 AT E398628 T1 ATE398628 T1 AT E398628T1 AT 01949791 T AT01949791 T AT 01949791T AT 01949791 T AT01949791 T AT 01949791T AT E398628 T1 ATE398628 T1 AT E398628T1
Authority
AT
Austria
Prior art keywords
alpha
difluoro
producing
intermediate product
oxidation process
Prior art date
Application number
AT01949791T
Other languages
English (en)
Inventor
Frederick David Albinson
Steven John Coote
John Malcolm Robinson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE398628T1 publication Critical patent/ATE398628T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT01949791T 2000-07-21 2001-07-20 Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro- ATE398628T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017988.7A GB0017988D0 (en) 2000-07-21 2000-07-21 Novel process

Publications (1)

Publication Number Publication Date
ATE398628T1 true ATE398628T1 (de) 2008-07-15

Family

ID=9896132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949791T ATE398628T1 (de) 2000-07-21 2001-07-20 Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-

Country Status (26)

Country Link
US (1) US20040043974A1 (de)
EP (1) EP1301526B1 (de)
JP (1) JP2004504403A (de)
KR (1) KR100787293B1 (de)
CN (1) CN1315864C (de)
AT (1) ATE398628T1 (de)
AU (2) AU7090601A (de)
BR (1) BR0110430A (de)
CA (1) CA2406963A1 (de)
CY (1) CY1108553T1 (de)
CZ (1) CZ302592B6 (de)
DE (1) DE60134472D1 (de)
DK (1) DK1301526T3 (de)
ES (1) ES2307628T3 (de)
GB (1) GB0017988D0 (de)
HK (1) HK1056179B (de)
HU (1) HUP0301108A3 (de)
IL (2) IL152348A0 (de)
MX (1) MXPA02010967A (de)
NO (1) NO324836B1 (de)
NZ (1) NZ522083A (de)
PL (1) PL206652B1 (de)
PT (1) PT1301526E (de)
SI (1) SI1301526T1 (de)
WO (1) WO2002008243A1 (de)
ZA (1) ZA200208372B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
WO2002012266A1 (en) 2000-08-05 2002-02-14 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
PT1383786E (pt) 2001-04-30 2008-12-30 Glaxo Group Ltd Derivados anti-inflamatórios de éster 17.beta-carbotioato de androstano com um grupo éster ciclíco na posição 17.alfa
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
EP1466920A1 (de) * 2003-04-04 2004-10-13 Alpharma APS Verfahren zur Herstellung von steroidal 17 beta-carbothioates
WO2004087731A1 (en) * 2003-04-04 2004-10-14 Alpharma Aps Process for the preparation of steroidal carbothioic acid derivatives and intermediates
EP1526139A1 (de) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. Verfahren zur Herstellung von hochreinen Androstan-17-beta-carbonsäuren und Androstan-17-beta-fluoromethyl-thiocarbonsäureestern
GB0612027D0 (en) 2006-06-16 2006-07-26 Glaxo Group Ltd Novel process
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
JP2013536835A (ja) 2010-09-01 2013-09-26 カディラ・ヘルスケア・リミテッド プロピオン酸/フロ酸フルチカゾンを調製するための方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
US4198336A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. Chemical process for preparing androsta-4-ene 17α-carboxylic acids
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
CY1291A (en) * 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
DE69609199T2 (de) * 1995-12-29 2001-03-01 Glaxo Group Ltd., Greenford Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
WO2001074599A1 (en) * 2000-04-04 2001-10-11 Celanese International Corporation Ink receptive coating compositions containing poly(vinyl alcohol) grafted with amine functional groups
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions

Also Published As

Publication number Publication date
HUP0301108A3 (en) 2008-04-28
HUP0301108A2 (hu) 2003-08-28
DE60134472D1 (de) 2008-07-31
CN1437610A (zh) 2003-08-20
NO324836B1 (no) 2007-12-17
HK1056179B (en) 2009-07-17
DK1301526T3 (da) 2008-10-06
CZ20023472A3 (cs) 2003-04-16
KR100787293B1 (ko) 2007-12-20
US20040043974A1 (en) 2004-03-04
CY1108553T1 (el) 2014-04-09
ES2307628T3 (es) 2008-12-01
WO2002008243A1 (en) 2002-01-31
NO20025054L (no) 2002-11-05
ZA200208372B (en) 2004-02-11
EP1301526B1 (de) 2008-06-18
BR0110430A (pt) 2003-07-08
NO20025054D0 (no) 2002-10-21
SI1301526T1 (sl) 2008-10-31
AU2001270906B2 (en) 2005-10-13
KR20030028736A (ko) 2003-04-10
PL206652B1 (pl) 2010-09-30
AU7090601A (en) 2002-02-05
JP2004504403A (ja) 2004-02-12
PL359462A1 (en) 2004-08-23
NZ522083A (en) 2004-06-25
CZ302592B6 (cs) 2011-07-27
MXPA02010967A (es) 2003-03-27
CA2406963A1 (en) 2002-01-31
CN1315864C (zh) 2007-05-16
IL152348A0 (en) 2003-05-29
HK1056179A1 (en) 2004-02-06
EP1301526A1 (de) 2003-04-16
PT1301526E (pt) 2008-09-09
IL152348A (en) 2008-08-07
GB0017988D0 (en) 2000-09-13

Similar Documents

Publication Publication Date Title
ATE398628T1 (de) Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-
DE50310614D1 (de) Verfahren zur herstellung von c13-alkoholgemischen
DE69932864D1 (de) Neue Fettsäureanaloge zur Behandlung des Bluthochdrucks
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
MXPA04000634A (es) Barra de detergente mejorada y un proceso para fabricacion.
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
ATE359272T1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
ATE272061T1 (de) Friedel-craft verfahren zur herstellung von thioxanthonen
ATE266618T1 (de) Verfahren zur herstellung von zwischenprodukten für pestizide
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
ATE299862T1 (de) Verfahren zur herstellung von ketiminen
ATE249450T1 (de) Verfahren zur herstellung von l-ascorbinsäure
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60112241D1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
ATE348094T1 (de) Verfahren zur herstellung von optisch aktiven 3,7-dimethyl-6-octenol und verfahren zur herstellung von zwischenprodukt dafür
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
PL353291A1 (en) Novel compounds, method of obtaining them, their application as pigments and composition containing them
DE60114889D1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
DE59702822D1 (de) Verfahren zur herstellung von 2-fluor-1-cyclopropancarbonsäurederivaten durch reduktive enthalogenierung
ATE297376T1 (de) Verfahren zur herstellung von alkyl-n- alkylanthranilate
DE50114223D1 (de) Verfahren zur herstellung von 1-substituierten 5-chlor-4methylpyrazolen
IL145017A (en) METHOD FOR PRODUCING 4,4-DIMETHYL-3beta-HYDROXYPREGNA-8,14-DIENE-21 -CARBOXILIC ACID ESTERS AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD
ATE334958T1 (de) Verfahren zur herstellung von 3,4- dihydrobutansäure und derivaten davon aus substituierten pentosezuckern
DE60034254D1 (de) Verfahren zur herstellung von 5- und/oder 6-substituierten 2-hydroxybenzoesäureestern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1301526

Country of ref document: EP